CALCIOANTAGONISTAS FARMACOLOGIA PDF
unidad farmacología por aparatos sistemas. farmacología del aparato circulatorio . fármacos ionotropos. gasto cardíaco: volumen de sangre impulsado por el. Edición: Comisión de Farmacia y Terapéutica. Redacción: Servicio de Farmacología Clínica. Solicitud de Inclusión de nuevos Fármacos en la. Tamargo J. Farmacología clínica de los calcioantagonistas. Potenciales diferencias basadas en la duración de acción y tipo de formulación. Hipertensión
| Author: | Kazrajora Nimi |
| Country: | Anguilla |
| Language: | English (Spanish) |
| Genre: | Relationship |
| Published (Last): | 19 December 2015 |
| Pages: | 316 |
| PDF File Size: | 5.98 Mb |
| ePub File Size: | 11.91 Mb |
| ISBN: | 129-1-68472-926-3 |
| Downloads: | 48130 |
| Price: | Free* [*Free Regsitration Required] |
| Uploader: | Dailar |
Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: Vagal stimulation and atrial electrical remodeling. Rev Esp Cardiol ;6 Supl C: Am J Physiol ; PlosOne 8 Curr Opin Investig Drugs ; Reversal strategies for non-vitamin K antagonist oral anticoagulants: Angiotensin II, angiotensin II antagonists and calcioantgonistas and their modulation of cardiac repolarization.
Sus ventajas y sus limitaciones. Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients. Expert Opin Drug Discov.
Novel therapeutic targets for the treatment of heart failure.
Med Clin Barc ; Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: Pharmacol Ther ; Eur J Clin Pharmacol. Rev Esp Cardiol ;6 Supl B: Role of protein kinase Cx.
Departamento de Farmacología
Nitric oxide NO scavenging and NO protecting effects of quercetin and its biological significance in vascular smooth muscle. Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: Cardiac electrophysiological effects of nitric oxide. The impact of new and emerging clinical data on treatment strategies for atrial fibrillation.
New Antihypertensive Drugs Under Development. Trends Pharmacol Sci ; Ruilope LM, Tamargo J. Expert Opin Investig Drugs ; Comparison of agents that affect aldosterone action.
J Am Coll Cardiol ; Expert Opin Drug Saf ;5: Seminars in Nephrology ; Nitric oxide blocks hKv1. Endocannabinoids and cannabinoid analogues block cardiac hKv1. Rev Esp Cardiol ;10 supl B: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: Propafenone blocks human cardiac Kir2. Epub May Epub Jun 9.
Publicaciones en revistas del jcr
Antihypertensive efficacy and tolerability oflercanidipine in daily clinical practice. Narrow therapeutic index drugs: Effects of atorvastatin and simvastatin on atrial plateau currents.
New investigational drugs for the management of acute heart failure syndromes. New Drugs for Acute Heart Failure. Eur J Heart Fail. Investigational positive inotropic agents for acute heart failure. Expert Opin Drug Saf ; Platelet content of nitric oxide synthase 3 phosphorylated at serie is associated with the functional response of platelet caocioantagonistas aspirin.
Circ Cardiovasc Genet ;4: